B

Brainstorm Cell Therapeutics

32 employees

Brainstorm is a developing innovative, autologous stem cell therapies for highly debilitating neurodegenerative disorders.

Basic info

Industry

biotechnology research

Sectors

Biotechnology
drug development
Therapeutics
ALS
neurodegenerative diseases
stem cell therapy
Medical
Health Care

Date founded

2004

Funding rounds raised

Total raised

$10M

from 3 investors over 3 rounds

B

Brainstorm Cell Therapeutics raised $10M on March 6, 2020

Investors: Abbhi Capital

B

Brainstorm Cell Therapeutics raised $495K on November 14, 2019

Investors: National MS Society

B

Brainstorm Cell Therapeutics raised $5M on July 24, 2014

Investors: Unidade Mista de Saúde de Vista Alegre do Alto

FAQ